Waters Zukünftiges Wachstum
Future Kriterienprüfungen 2/6
Waters wird ein jährliches Gewinn- und Umsatzwachstum von 7.6% bzw. 4.9% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 10% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 26.5% betragen.
Wichtige Informationen
8.2%
Wachstumsrate der Gewinne
10.3%
EPS-Wachstumsrate
| Life Sciences Gewinnwachstum | 16.2% |
| Wachstumsrate der Einnahmen | 5.0% |
| Zukünftige Eigenkapitalrendite | 24.8% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 01 Aug 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Should You Think About Buying Waters Corporation (NYSE:WAT) Now?
Jul 19
Waters Corporation's (NYSE:WAT) Business Is Yet to Catch Up With Its Share Price
May 26Waters Corporation: Still Struggling A Bit
May 24Estimating The Intrinsic Value Of Waters Corporation (NYSE:WAT)
Apr 25Is It Too Late To Consider Buying Waters Corporation (NYSE:WAT)?
Apr 07We Think Waters (NYSE:WAT) Can Stay On Top Of Its Debt
Mar 19Waters Corporation: A Great (Share Price) Run
Mar 11Waters Corporation (NYSE:WAT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$323
Feb 09Waters Corporation's (NYSE:WAT) Price Is Out Of Tune With Earnings
Jan 09Waters Corporation: High Quality Niche Company In Mass Spectrometry
Dec 28A Look At The Fair Value Of Waters Corporation (NYSE:WAT)
Dec 10Is There Now An Opportunity In Waters Corporation (NYSE:WAT)?
Nov 25Waters Corporation: Appealing Levels Are Offset By Weaker Performance
Nov 13Waters (NYSE:WAT) Seems To Use Debt Quite Sensibly
Oct 26Waters Corporation: Buybacks Ceased, Incremental Returns Languishing (Rating Downgrade)
Sep 27What Does Waters Corporation's (NYSE:WAT) Share Price Indicate?
Aug 21Calculating The Intrinsic Value Of Waters Corporation (NYSE:WAT)
Aug 03Waters Corporation: Temporary Headwinds Present A Buying Opportunity
Jul 18These 4 Measures Indicate That Waters (NYSE:WAT) Is Using Debt Reasonably Well
Jul 16Is Now The Time To Look At Buying Waters Corporation (NYSE:WAT)?
May 23A Look At The Intrinsic Value Of Waters Corporation (NYSE:WAT)
Apr 29Here's Why Waters (NYSE:WAT) Can Manage Its Debt Responsibly
Apr 08What Is Waters Corporation's (NYSE:WAT) Share Price Doing?
Feb 22Waters Q4 2022 Earnings Preview
Feb 14Waters Corp.: Now Best Price-Positioned Medical Services Stock
Feb 02Waters Corporation (NYSE:WAT) Shares Could Be 31% Above Their Intrinsic Value Estimate
Jan 26Does Waters (NYSE:WAT) Have A Healthy Balance Sheet?
Jan 05Should You Think About Buying Waters Corporation (NYSE:WAT) Now?
Nov 24Waters Corporation: Tactical Buy Seeking Upside Objectives Of $345, $363
Nov 16Waters Q3 2022 Earnings Preview
Oct 31Estimating The Fair Value Of Waters Corporation (NYSE:WAT)
Oct 19Waters announces €6M R&D investment at Wexford facility
Oct 07Is Waters (NYSE:WAT) Using Too Much Debt?
Oct 01Do Waters' (NYSE:WAT) Earnings Warrant Your Attention?
Aug 23Waters Corporation: Thesis Unchanged
Aug 18Is There Now An Opportunity In Waters Corporation (NYSE:WAT)?
Aug 05Waters Non-GAAP EPS of $2.75 beats by $0.08, revenue of $714M beats by $7.23M
Aug 02Calculating The Fair Value Of Waters Corporation (NYSE:WAT)
Jul 18These 4 Measures Indicate That Waters (NYSE:WAT) Is Using Debt Reasonably Well
Jun 30Waters Corporation: Shares Are Getting Cheaper, But They Aren't Cheap Enough
Jun 01Here's Why We Think Waters (NYSE:WAT) Is Well Worth Watching
May 15Is Now The Time To Look At Buying Waters Corporation (NYSE:WAT)?
Apr 29Waters Corporation (NYSE:WAT) Shares Could Be 22% Below Their Intrinsic Value Estimate
Apr 11Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 3,254 | 749 | 757 | 935 | 11 |
| 12/31/2025 | 3,075 | 707 | 809 | 957 | 17 |
| 12/31/2024 | 2,916 | 620 | 715 | 842 | 17 |
| 6/29/2024 | 2,877 | 596 | 561 | 705 | N/A |
| 3/30/2024 | 2,909 | 604 | 514 | 669 | N/A |
| 12/31/2023 | 2,956 | 642 | 442 | 603 | N/A |
| 9/30/2023 | 2,995 | 653 | 390 | 571 | N/A |
| 7/1/2023 | 2,992 | 675 | 387 | 572 | N/A |
| 4/1/2023 | 2,966 | 689 | 425 | 610 | N/A |
| 12/31/2022 | 2,972 | 708 | 428 | 612 | N/A |
| 10/1/2022 | 2,950 | 697 | 465 | 631 | N/A |
| 7/2/2022 | 2,901 | 702 | 477 | 641 | N/A |
| 4/2/2022 | 2,868 | 705 | 565 | 727 | N/A |
| 12/31/2021 | 2,786 | 693 | 579 | 747 | N/A |
| 10/2/2021 | 2,736 | 695 | 626 | 797 | N/A |
| 7/3/2021 | 2,671 | 660 | 642 | 802 | N/A |
| 4/3/2021 | 2,509 | 616 | 697 | 857 | N/A |
| 12/31/2020 | 2,365 | 522 | 618 | 791 | N/A |
| 9/26/2020 | 2,295 | 504 | 536 | 715 | N/A |
| 6/27/2020 | 2,278 | 515 | 495 | 691 | N/A |
| 3/28/2020 | 2,358 | 537 | 430 | 619 | N/A |
| 12/31/2019 | 2,407 | 592 | 479 | 643 | N/A |
| 9/28/2019 | 2,405 | 577 | 491 | 633 | N/A |
| 6/29/2019 | 2,406 | 580 | 475 | 631 | N/A |
| 3/30/2019 | 2,403 | 591 | 467 | 604 | N/A |
| 12/31/2018 | 2,420 | 594 | 508 | 604 | N/A |
| 9/29/2018 | 2,392 | 55 | 489 | 615 | N/A |
| 6/30/2018 | 2,380 | 51 | 536 | 623 | N/A |
| 3/31/2018 | 2,342 | 27 | N/A | 699 | N/A |
| 12/31/2017 | 2,309 | 20 | N/A | 698 | N/A |
| 9/30/2017 | 2,251 | 548 | N/A | 679 | N/A |
| 7/1/2017 | 2,212 | 537 | N/A | 674 | N/A |
| 4/1/2017 | 2,190 | 533 | N/A | 656 | N/A |
| 12/31/2016 | 2,167 | 522 | N/A | 643 | N/A |
| 10/1/2016 | 2,125 | 498 | N/A | 623 | N/A |
| 7/2/2016 | 2,099 | 490 | N/A | 613 | N/A |
| 4/2/2016 | 2,057 | 467 | N/A | 567 | N/A |
| 12/31/2015 | 2,042 | 469 | N/A | 573 | N/A |
| 10/3/2015 | 2,040 | 469 | N/A | 568 | N/A |
| 7/4/2015 | 2,032 | 467 | N/A | 557 | N/A |
| 4/4/2015 | 2,019 | 457 | N/A | 550 | N/A |
| 12/31/2014 | 1,989 | 432 | N/A | 512 | N/A |
| 9/27/2014 | 1,971 | 422 | N/A | 493 | N/A |
| 6/28/2014 | 1,935 | 406 | N/A | 470 | N/A |
| 3/29/2014 | 1,904 | 399 | N/A | 473 | N/A |
| 12/31/2013 | 1,904 | 450 | N/A | 485 | N/A |
| 9/28/2013 | 1,861 | 484 | N/A | 473 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: WATDas prognostizierte Gewinnwachstum (7.6% pro Jahr) liegt über der Sparquote (2.4%).
Ertrag vs. Markt: WATDie Erträge des Unternehmens (7.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (14.8% pro Jahr).
Hohe Wachstumserträge: WATDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: WATDie Einnahmen des Unternehmens (4.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.7% pro Jahr).
Hohe Wachstumseinnahmen: WATDie Einnahmen des Unternehmens (4.9% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: WATDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (26.5%)